跳至主要内容
临床试验/NCT06362915
NCT06362915招募中1 期

Analgesic Effect of Illiohypogastic & Ilioinguinal Nerve Block in TAVR - TF (Prospective Randomized Study)

Ain Shams University2 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2024年1月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
52
试验地点
2
主要终点
Extra Demand of sedation

研究概览

简要总结

The purpose of the study is to compare the effect of illiohypogastric and ilioinguinal nerve block with the local infiltration with lidocaine in patients undergoing TAVI

详细描述

This prospective, randomized, double blinded study will take place at cardiothoracic academy, Ain Shams University hospitals, Cairo, Egypt. In this study, participants, care providers and outcomes assessors will be ignorant of the treatment allocation. The study will start after obtaining the ethical approval & will continue for a 1 year. All patients will sign written informed consent before inclusion.

Patients fulfilling criteria for TAVI regarding age & pathology of aortic valve will be included in the study.

Exclusion criteria:

Refusal of the patients, Patients with neurological disease (Disturbed conscious level or psychiatric illness) severe respiratory disease need mechanical ventilation or need respiratory support, coagulation abnormalities, infection at site of injection.

After confirming the diagnosis & preoperative sizing of the valve by CT heart and then confirmation that no need for TEE guidance of the procedure, we will include 60 patients and then will be divided into two groups according to the technique of local anesthesia for the site of puncture.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

  • Group (A): will receive blind local infiltration in femoral region on the operation side by an experienced anesthesiologist using 20 ml lidocaine 1% (9).
  • Group (B): will receive ultrasound-guided ilioinguinal/iliohypogastric nerve block using 20 ml Bupivicane 0.25% by an experienced anesthesiologist.

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients fulfilling criteria for TAVI regarding age & pathology of aortic valve will be included in the study.

排除标准

  • Refusal of the patients, Patients with neurological disease (Disturbed conscious level or psychiatric illness) severe respiratory disease need mechanical ventilation or need respiratory support, coagulation abnormalities, infection at site of injection.

研究组 & 干预措施

Group A:Lidocaine group

Active Comparator

will receive blind local infiltration in femoral region on the operation side by an experienced anesthesiologist using 20 ml lidocaine 1%

干预措施: Lidocaine (Drug)

Group B:Bupivacaine group

Active Comparator

will receive ultrasound-guided ilioinguinal/iliohypogastric nerve block using 20 ml Bupivicane 0.25% by an experienced anesthesiologist

干预措施: Bupivacain (Drug)

结局指标

主要结局

Extra Demand of sedation

时间窗: All through procedure

Need for increments of narcotics or propofol will be recorded and collected at the end of the procedure.

次要结局

  • Patient and surgeon satisfaction(all through the procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

maha sadek El Derh

Assistant professor of Anesthesia

Ain Shams University

研究点 (2)

Loading locations...

相似试验